---

$13.54

-0.3860 ( -2.77% ) 69.4K

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-12-29	Sale	-4100.00	WILSON KAREN J
2023-12-29	Sale	-4100.00	Ashe Carol Gail
2023-12-29	Sale	-4100.00	Venkatesan Jay
2023-12-29	Sale	-4100.00	ADAMS JULIAN
2023-12-29	Sale	-4100.00	RUFFOLO ROBERT R
2023-12-26	Buy	1213000.00	Chudnovsky Yekaterina